Initiator Financial Statements From 2010 to 2026
| INIT Stock | 3.03 0.02 0.66% |
Check Initiator Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Initiator Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Initiator financial statements analysis is a perfect complement when working with Initiator Pharma Valuation or Volatility modules.
Initiator |
Initiator Pharma AS Company Current Valuation Analysis
Initiator Pharma's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Initiator Pharma Current Valuation | 256.25 M |
Most of Initiator Pharma's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Initiator Pharma AS is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Initiator Pharma AS has a Current Valuation of 256.25 M. This is much higher than that of the sector and significantly higher than that of the Biotechnology industry. The current valuation for all Sweden stocks is notably lower than that of the firm.
Initiator Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Initiator Pharma's current stock value. Our valuation model uses many indicators to compare Initiator Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Initiator Pharma competition to find correlations between indicators driving Initiator Pharma's intrinsic value. More Info.Initiator Pharma AS is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Initiator Pharma's earnings, one of the primary drivers of an investment's value.About Initiator Pharma Financial Statements
Initiator Pharma shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Initiator Pharma investors may analyze each financial statement separately, they are all interrelated. The changes in Initiator Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Initiator Pharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Initiator Stock Analysis
When running Initiator Pharma's price analysis, check to measure Initiator Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Initiator Pharma is operating at the current time. Most of Initiator Pharma's value examination focuses on studying past and present price action to predict the probability of Initiator Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Initiator Pharma's price. Additionally, you may evaluate how the addition of Initiator Pharma to your portfolios can decrease your overall portfolio volatility.